SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Trickle Portfolio
An SI Board Since October 2000
Posts SubjectMarks Bans
1784 65 0
Emcee:  tuck Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1184Hi Tuck, welcome back. Have you taken a look at the Fluidigm website recently ?nigel bates-8/15/2002
1183QGENF indeed reported good numbers from academics and its core biz. It was theituck-8/14/2002
1182SIAL's full numbers: >><pre> SIGMA-ALDRItuck-8/13/2002
1181I guess mass specs are still selling, and ABI will probably be cutting back on dtuck-8/13/2002
1180Going back to stuff I missed while out being bitten by mosquitos and trudging thtuck-8/13/2002
1179The usual terse quarterly from Techne, which isn't moving much. >>Tectuck-8/13/2002
1178PCOP is attractive because it is trading at cash value. it does not take rocked Spekulatius-8/13/2002
1177Another report is from NZYM, another company that Trickle has dropped from offictuck-8/12/2002
1176Might have to look at PCOP again. Meanwhile Bruker AXS (BAXS) beats its estimattuck-8/12/2002
1175I bought some PCOP today. This stock is trading at cash value (150M$) yet they mSpekulatius-8/1/2002
1174Waters Licenses Mass Spectrometry Patent Portfolio from Bruker Daltonics BOSTON-keokalani'nui-8/1/2002
1173Recent GS report: Overall, we expect life sciences tools companies to report inmopgcw-7/16/2002
1172From Feuerstein on TSC: Monday's Pfizer (PFE:NYSE - news - commentary - restom pope-7/15/2002
1171>>BILLERICA, Mass.--(BW HealthWire)--July 8, 2002--Bruker Daltonics Inc. (tuck-7/8/2002
1170Perspective on the QGENF statement: >>Qiagen, Bruised by Weak Pharma, Maytuck-7/6/2002
1169A trickle of tonic for the Trickle troops: >>SAN DIEGO--(BW HealthWire)--tuck-7/3/2002
1168Some sector commentary that I put on the firesale thread: Message 17691576 As tuck-7/3/2002
1167Explains the price weakness in TECH. -13%. It finally caught up with IBB.keokalani'nui-7/3/2002
1166Ouch! AFFX, which also has a sizeable short position is also getting whacked intuck-7/3/2002
1165I'm sure everybody has seen this by now, but just in case, from Briefing: &tom pope-7/3/2002
1164SIAL manages to get rid of its diagnostic unit: >>NEW YORK -(Dow Jones)- tuck-7/1/2002
1163>>a new potential trickle company? CTI Molecular 10.7M Shr IPO Priced At tuck-7/1/2002
1162a new potential trickle company? CTI Molecular 10.7M Shr IPO Priced At $17 Eamopgcw-6/21/2002
1161From GS conference: Wednesday included presentations by three Life Sciences Toomopgcw-6/19/2002
1160MDZ not hurt too badly, but QGENF, which is sporting an ENORMOUS -- 7.33 milliontuck-6/13/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):